DrugPatentWatch Database Preview
ARANESP Drug Profile
Summary for Tradename: ARANESP
| Patents: | 77 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ARANESP |
Pharmacology for ARANESP
| Ingredient-type | Erythropoietin |
| Physiological Effect | Increased Erythroid Cell Production |
US Patents for ARANESP
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 010 | 2001-09-17 | See Pricing | Bayer Intellectual Property GMBH (Monheim, DE) | 2026-12-05 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 010 | 2001-09-17 | See Pricing | CHONG KUN DANG PHARMACEUTICAL CORP. (Seoul, KR) | 2031-10-18 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 010 | 2001-09-17 | See Pricing | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK MEMORIAL SLOAN-KETTERING CANCER CENTER (New York, NY) | 2034-12-23 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 010 | 2001-09-17 | See Pricing | Corning Incorporated (Corning, NY) | 2037-10-23 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 010 | 2001-09-17 | See Pricing | 2030-02-02 | RX | search | ||
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 010 | 2001-09-17 | See Pricing | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| Amgen | ARANESP | darbepoetin alfa | VIAL; SUBCUTANEOUS | 103951 | 010 | 2001-09-17 | See Pricing | Bayer Intellectual Property GmbH (Monheim, DE) | 2031-04-05 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for ARANESP
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| El Salvador | 2009003152 | See Pricing |
| Israel | 198581 | See Pricing |
| China | 1051936 | See Pricing |
| South Korea | 20090092822 | See Pricing |
| New Zealand | 574081 | See Pricing |
| European Patent Office | 2233156 | See Pricing |
| Japan | 5326092 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ARANESP
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 300075 | Netherlands | See Pricing | PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001 20010608 |
| 01C0050 | France | See Pricing | PRODUCT NAME: DARBEPOETIN ALFA; REGISTRATION NO/DATE: EU/1/01/185/001 20010608 |
| SPC/GB01/055 | United Kingdom | See Pricing | PRODUCT NAME: DARBEPOETIN ALFA; REGISTERED: UK EU/1/01/185/001-030 20010608 |
| 43/2001 | Austria | See Pricing | PRODUCT NAME: DARBEPOETIN-ALFA; REGISTRATION NO/DATE: EU/1/01/185/001-030 20010608 |
| SPC028/2001 | Ireland | See Pricing | SPC028/2001: 20031204, EXPIRES: 20160607 |
| PA2004015 | Lithuania | See Pricing | PRODUCT NAME: DARBEPOETINAS ALFA (ASN30 THR32 VAL87 ASN88 THR90 EPO); REGISTRATION NO/DATE: EU/1/01/185/001-030 20010608 |
| SZ 43/2001 | Austria | See Pricing | PRODUCT NAME: DARBEPOETIN-ALFA |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
